Rang	Name	Position
1	Dr. Mark Manfredi Ph.D.	President, CEO & Director
2	Dr. Jotin Marango M.D., Ph.D.	COO, CFO, Head of Corporate Development & Treasurer
3	Ms. Rebecca Cohen	Senior VP of Investor Relations, Corporate Strategy & Communication
4	Mr. Jeffrey Ecsedy Ph.D.	Chief Development Officer
5	Mr. Bob Lally	Senior Vice President of Finance & Operations
6	Mr. David Damphousse M.S.	Senior Vice President of Clinical Development Operations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Blue Owl Capital Holdings LP	9,77%	70,20 Mio. USD
2	BML Capital Management LLC	9,62%	69,16 Mio. USD
3	Bvf Inc	9,56%	68,75 Mio. USD
4	Orbimed Advisors, LLC	8,45%	60,74 Mio. USD
5	Deep Track Capital, LP	6,01%	43,17 Mio. USD
6	Omega Fund Management LLC	5,37%	38,60 Mio. USD
7	Vanguard Group Inc	3,37%	24,26 Mio. USD
8	Adage Capital Partners Gp LLC	1,91%	13,73 Mio. USD
9	NEA Management Company, LLC	1,43%	10,30 Mio. USD
10	Sofinnova Ventures	0,91%	6,57 Mio. USD
11	BlackRock Inc	0,83%	5,98 Mio. USD
12	Geode Capital Management, LLC	0,76%	5,44 Mio. USD
13	Renaissance Technologies Corp	0,70%	5,05 Mio. USD
14	Aldebaran Capital LLC	0,58%	4,16 Mio. USD
15	Acadian Asset Management LLC	0,50%	3,60 Mio. USD
16	Jacobs Levy Equity Management, Inc.	0,47%	3,40 Mio. USD
17	Bridgeway Capital Management, LLC	0,37%	2,63 Mio. USD
18	Two Sigma Advisers, LLC	0,34%	2,47 Mio. USD
19	UBS Group AG	0,24%	1,73 Mio. USD
20	State Street Corp	0,22%	1,58 Mio. USD